Serrano-Villar, Sergio <br/><br/>
Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.  [electronic resource] 

 -  PLoS pathogens  Jan 2016 
 - e1005381 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1553-7374 
<br/><br/><label>Standard No.: </label>10.1371/journal.ppat.1005381  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alkynes<br/>Anti-HIV Agents--administration & dosage<br/>Benzoxazines--administration & dosage<br/>CCR5 Receptor Antagonists--administration & dosage<br/>Chromatography, High Pressure Liquid<br/>Cyclohexanes--administration & dosage<br/>Cyclopropanes<br/>Drug Combinations<br/>Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination--administration & dosage<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Flow Cytometry<br/>HIV Infections--drug therapy<br/>HIV Integrase Inhibitors--administration & dosage<br/>Humans<br/>Immunity, Mucosal--drug effects<br/>Lymphocyte Activation--drug effects<br/>Male<br/>Maraviroc<br/>Pilot Projects<br/>Raltegravir Potassium--administration & dosage<br/>T-Lymphocyte Subsets--drug effects<br/>Triazoles--administration & dosage